Pharmaxis Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.03 |
Market Cap |
AUD96.61 M |
Shares Outstanding |
394.32 M |
Public Float |
320.43 M |
Address |
20 Rodborough Road Sydney New South Wales (NSW) 2086 Australia |
Employees | - |
Website | http://www.pharmaxis.com.au |
Updated | 07/08/2019 |
Pharmaxis Ltd. operates as a specialty pharmaceutical company, which engages in the development and commercialization of therapeutic products for chronic respiratory disorders, autoimmune diseases, and improved lung function test. It operates through the following segments: Bronchitol and Aridol Business and New Drug Development. The Bronchitol and Aridol Business segment covers the ongoing clinical development, manufacture, and sale of the Bronchitol and Aridol globally. |